Contrave 8Mg-90Mg Extended-Release Tablet

DRUG3 trials

Sponsors

University of California, Los Angeles, St. Joseph's Healthcare Hamilton

Conditions

ADHDCognitive FunctionObesityRelapseStimulant Use

Early Phase 1

Relapse Prevention in Stimulant Use Disorder

WithdrawnNCT04553263

University of California, Los AngelesADHD, Cognitive Function, Relapse +1

Start: 2023-06-11End: 2025-01-11Updated: 2023-09-22

Phase 4

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery

St. Joseph's Healthcare HamiltonObesity

Start: 2021-04-01End: 2023-12-31Updated: 2023-08-03

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program.

St. Joseph's Healthcare HamiltonObesity

Start: 2021-02-01End: 2023-12-31Updated: 2023-08-03